)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Marksans Pharma
Marksans Pharma (MARKSANS) investor relations material
Marksans Pharma Q1 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 26/27 earnings summary13 Aug, 2026
Executive summary
Q1 FY27 revenue rose 35.6% YoY to ₹840.8 crore; record EBITDA of ₹213 crore and PAT of ₹159.4 crore, with quarter-end cash of ₹1,058 crore.
UK & Europe revenue surged 74.7% YoY to ₹356 crore, including ₹44 crore from QliniQ; acquisitions and broad-based growth strengthened the European platform.
Management maintained FY27 guidance and plans to pursue geographic expansion, product launches and selective acquisitions.
Financial highlights
Operating revenue was ₹840.8 crore versus ₹620 crore in Q1 FY26, up 35.6% YoY; underlying growth excluding QliniQ was 28.5%.
Gross profit increased 38.9% YoY to ₹497.3 crore; gross margin expanded 138 bps to 59.1%.
EBITDA more than doubled to ₹213 crore; margin rose 919 bps YoY to 25.3%.
PAT rose 173.9% YoY to ₹159.4 crore; net profit margin was 18.4%.
Operating cash flow was ₹185 crore; after ₹33 crore net CapEx, free cash flow was ₹152 crore.
Outlook and guidance
FY27 revenue growth guidance of 15%-20% and EBITDA margin guidance of 20%-21% maintained; management said 21%-22% margin is achievable.
Revenue expected to improve in Q2 versus Q1, with Q3 potentially strongest; management expects to meet its margin plan.
Management reiterated a ₹4,000 crore revenue target within two years and a goal to double revenue within five years.
Europe is expected to generate EUR 180 million; QliniQ is expected to contribute ₹150-175 crore revenue in FY27.
Longer-term ambitions include ₹1,000 crore revenue in Europe within five years and U.S. benchmarks of $300 million near term and $400 million longer term.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Marksans Pharma
- FY26 saw record revenue, profit growth, margin gains, and continued global expansion.MARKSANS
Q4 25/26 - Q3 FY26 saw record revenue, margin gains, global expansion, and higher employee costs.MARKSANSQ3 25/26
- Q2 FY26 saw 16% revenue and 70% net profit growth, with strong cash flow and expansion plans.MARKSANSQ2 25/26
- Revenue up 5% YoY with margin gains, but profits fell on one-offs and forex losses.MARKSANSQ1 25/26
- Q2 FY25 revenue grew 20.8% year-on-year, with record EBITDA and strong U.S. growth.MARKSANSQ2 24/25
- Q1 FY25 saw strong revenue and profit growth, margin gains, and new facility ramp-up.MARKSANSQ1 24/25
- Record Q3 PAT and robust U.S. growth drive strong results and positive outlook.MARKSANSQ3 24/25
- FY25 saw record revenue and profit, led by 35% US growth, OTC strength, and margin expansion.MARKSANSQ4 24/25
Next Marksans Pharma earnings date
Q2 26/2713 Nov, 2026
Marksans Pharma
Next Marksans Pharma earnings date
Q2 26/2713 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage